Veri MedTech Holdings, Inc. (VRHI) Stock Concentration Calculator
Calculator · free · no signup · VRHIQuantify Veri MedTech Holdings, Inc. concentration risk. Drawdown impact at 30 / 50 / 70%, with the tax-aware trade-off between selling down and hedging.
Beta · invite-only · AlphaLatitude Inc. · Free Tools
Your inputs
Adjust — results update instantly.Position & portfolio
Tax
Most fee-only advisors target ≤10% in any single name. You're at 67%.
Estimates only. Not financial advice.
Most sensitive to: Expected market return (±10% on this input swings best-plan wealth by ±$190,508).
Cost of fully de-concentrating
All three plans sell to 0% (no hedge).Sensitivity. If your expected position return drops below 19.6%/yr, lump-sum (sell everything today) beats every spread plan above.
Build your own plan
Toggle below — chart updates live. Sell buttons show the slice.Tech / Software single names hit a 50%+ peak-to-trough drawdown in roughly 1 of every 5 rolling 3-year windows over 2014–2024. Even mega-caps aren’t exempt.
Tax brackets: 2026 · Estimates only — not financial advice.
Estate note. Heirs receive a stepped-up basis at death (§1014), eliminating built-in gain on inherited shares. Older holders who plan to bequeath rather than sell may rationally never de-concentrate.
You sized one position's risk. The beta integrates hedging, sell-down, and tax timing into one optimized plan.
Request beta access →About Veri MedTech Holdings, Inc.
Veri MedTech Holdings, Inc. (VRHI) is a public Vertical SaaS company.
OTC; cannabis telehealth.
Equity grants at Veri MedTech Holdings, Inc. typically include incentive stock options (ISOs), non-qualified stock options (NSOs), and restricted stock units (RSUs).
Veri Medtech Holdings (OTC: VRHI) operates Veriheal, a telehealth platform founded in 2017 by Joshua Green and Samuel Adetunji that connects patients with state-licensed physicians for medical marijuana card certifications across multiple U.S. states. The Denver-based company has processed over 400,000 patient approvals through a network of roughly 400 physicians and reported cumulative revenue exceeding $100 million since inception, per a May 2025 company announcement. Veri Medtech filed an S-1 with the SEC in November 2025 seeking a $15 million Nasdaq uplisting at $4 per share, disclosing a going-concern risk tied to working capital deficits.
Sources: renaissancecapital.com · globenewswire.com
Equity comp at Veri MedTech Holdings, Inc.
- OTC Pink Sheet micro-cap (ticker VRHI) with a pending Nasdaq uplisting through a small follow-on offering. The equity plan permits both options and RSUs, though concrete grant terms are not publicly disclosed in detail. Liquidity is currently constrained by thin OTC trading volume rather than a vesting trigger.
- RSUs use single-trigger vesting: shares become yours as each portion vests on schedule, and the value is taxed as ordinary income at that point. No IPO or acquisition is required.
Sources: sec.gov
Researched 2026-05-11.
OptionsAhoy is an independent tool and is not affiliated with, endorsed by, or sponsored by Veri MedTech Holdings, Inc..
If a meaningful share of your net worth sits in VRHI, concentration risk is the question. This calculator quantifies drawdown impact at 30 / 50 / 70%, and the trade-off between selling down (tax cost now) versus hedging (option premium drag), auto-filled with VRHI's option-implied volatility.
All Veri MedTech Holdings, Inc. tools → · Use the generic Stock Concentration Calculator for any company.
Veri MedTech Holdings, Inc. equity questions
- How much VRHI stock is too much?
- There is no single threshold, but the larger the share of your net worth in one stock, the more a single bad year can set back your plans. The calculator above quantifies the drawdown impact at 30, 50, and 70 percent for your VRHI position and weighs selling down (which triggers capital-gains tax now) against hedging (which costs option premium).
- Does Veri MedTech Holdings, Inc. grant ISOs, NSOs, or RSUs?
- Equity compensation at Veri MedTech Holdings, Inc. typically takes the form of incentive stock options (ISOs), non-qualified stock options (NSOs), and restricted stock units (RSUs). Incentive stock options can trigger the alternative minimum tax (AMT) when you exercise. Restricted stock units are taxed as ordinary income when they vest.
- Do Veri MedTech Holdings, Inc. RSUs use double-trigger vesting?
- No. Veri MedTech Holdings, Inc. restricted stock units (RSUs) use single-trigger vesting: each tranche becomes yours as it vests on schedule, taxed as ordinary income at that point, with no liquidity event required.
One piece of the puzzle.
OptionsAhoy plans your Veri MedTech Holdings, Inc. equity alongside hedging, vesting, and de-concentration, across bullish, neutral, and bearish market scenarios. Free during beta.